Applicant/Recipient COVID-19 Update History

Significant page clean-up.

FAQs

• FAQs have been archived. See snapshot of Covid FAQs in place prior to clean-up effort.

Removed

• Reminder of COVID-19-Related Flexibilities for NIH Grants: Open Mike blog
• NOT-OD-20-086: Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
• NIH Open Mike: Clarifying NIH’s Approach to Granting ESI Extensions
• NOT-OD-21-052: Reminder – Requesting Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19
• NOT-OD-22-062 - Further Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
•  NOT-DE-21-021 - Notice to Extend Eligibility for Submission of Pathway to Independence Award Applications (K99/R00) to NIDCR due to Covid-19 disruptions
• NOT-GM-22-020 - Notice to Extend Eligibility for Submission of "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)" Applications Due to COVID–related Disruptions
• NOT-OD-22-007 - Flexibility Available to Lasker Clinical Research Scholars Affected by COVID-19
• NOT-AI-21-061 - Notice to Extend Eligibility for Submission of K99/R00 Pathway to Independence Award Applications (and Physician-Scientist K99/R00) due to COVID–related Disruptions
• NOT-AI-21-062 - Notice to Extend Eligibility for Submission to PAR-19-371, NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) due to COVID-related Disruptions
• NOT-DE-21-003: Continuation of Temporary Extension of Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) During the COVID-19 Pandemic
• NOT-OD-21-106: Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
• NOT-DK-21-054:  Temporary Extension of Eligibility for the NIDDK K01 Mentored Research Scientist Development Award During the COVID-19 Pandemic
• NOT-GM-20-026: Guidance for Cost-Related Flexibilities Available to Support of Competitive Research (SCORE) Award Recipients Affected by COVID-19 - NOT-GM-20-026
• NIH Implementation of OMB Memorandum M-20-26 "Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations"  - 6/25/2020
  • Update: Effective October 1, 2020, the flexibility for recipients to continue charging salaries and benefits to active NIH awards consistent with the recipients' policy of paying salaries (under unexpected or extraordinary circumstances), has ended. Any requests after that date will be considered by the funding IC on a case by case basis.  As a reminder, recipients must maintain appropriate records and cost documentation in order to substantiate the charging of any salaries and other project activities costs related to interruption of operations or services. 
• M-20-26 issued June 18, 2020:  Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations
• M-20-11 issued March 9, 2020: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19)
• NOT-OD-20-087: Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
• FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
• OHRP COVID-19 Resources
  • OHRP Guidance on COVID-19
• Considerations for New and Ongoing Human Subjects Research During the COVID-19 Public Health Emergency (Word) - 3/14/2022
• NOT-OD-21-006 - Exceptions to Use of a Single IRB During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency - 10/23/2020
• Link to COVID-19 Pandemic Contingency Planning for Animal Care and Use Programs page
  • Page no longer active - see COVID-19 Pandemic Contingency Planning for Animal Care and Use Programs page 5/16/2023 archive
• NOT-OD-21-080: Updated Notice of Limited Availability of Research Non-Human Primates
• Coronavirus Update: Additional Guidance for NIH Peer Reviewers (August/October 2021 Council) – January 5, 2021 (Expired)
• Coronavirus Update: Additional Guidance for NIH Peer Reviewers (Summer 2020 Meetings/August-October 2020 Council) – June 9, 2020 (Expired)
• Coronavirus Update: Guidance for Peer Reviewers
• Based on NIH Guidance on Travel and Meetings, in-person NIH peer review meetings are being held in alternate formats. Scientific review officers will be in contact with peer reviewers about these changes.
• Coronavirus Update for May 2022 Council Round 
• "Open Mike" Blog: COVID-19 Funding and Funding Opportunities 
• Supporting Yourself and Your Trainees During the Coronavirus Pandemic Online Workshops
• NIH Office of Intramural Training & Education: Virtual NIH Activities for Trainees Outside the NIH
• CDC Website: Coronavirus Disease 2019 (COVID-19) including its guidance for Institutes of Higher Education and for mental health and coping
• WHO Website: Coronavirus disease (COVID-19) outbreak
• Update on Covid-19 Flexibilities for the Research Community (video)
• NIH Message to Research Community on Flexibilities Needed for Covid-19 (video)

Proposal Submission & Award Management under Post Submission Materials

• Added NOT-OD-23-106: Revising the NIH/AHRQ/NIOSH Post-Submission Material Policy

Added under Guidance

• NOT-OD-23-095: Expiration of the COVID-19 Public Health Emergency

Added under Human Subjects & Clinical Trials

• NOT-OD-23-097: NIH Can No Longer Grant Common Rule Exceptions to the Use of a Single IRB for Multi-site Research After the COVID-19 Public Health Emergency Expiration Date of May 11, 2023

Added

• August/October 2023 Council Round

Proposal Submission & Award Management under Application Preparation

• Added NOT-OD-23-067:  Clarification and Guidance for Applicants Preparing Applications for the Spring 2023 Due Dates During the COVID-19 Pandemic
• Removed prior guidance notice NOT-OD-23-008 

Proposal Submission & Award Management under Post Submission Materials

• Added NOT-OD-23-066: Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2023 Councils
• Removed prior notices NOT-OD-22-113 and NOT-OD-22-047

Removed outdated notices regarding extensions for early career scientists

• NOT-HL-21-009: Updated Notice of Information: NHLBI Extensions for Career Development Award (K01, K08, K23, K25) Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19
• NOT-DA-21-046: Notice of Information: NIDA Extensions for NRSA Fellowships and Career Development Award Recipients Whose Career Trajectories Have Been Significantly Affected by COVID-19
• NOT-DK-21-019: NIDDK Notice of Continuation of Temporary Extension of Eligibility for the NIH Mentored Research Scientist Development Award (K01) Award During the COVID-19 Pandemic

Proposal Submission & Award Management under Application Preparation

• Added NOT-OD-23-008: Clarification and Guidance for Applicants Preparing Applications for the FALL 2022 Due Dates During the COVID-19 Pandemic
• Removed prior guidance notices NOT-OD-22-112 (Summer 2022 Due Dates) and NOT-OD-22-046 (Spring 2022 Due Dates) 

Proposal Submission & Award Management under Post Submission Materials

• Added NOT-OD-23-006: Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: May 2023 Councils
• Removed prior extension notice NOT-OD-21-179 (May 2022 Council)

Added

• NOT-OD-22-207: OLAW Waivers to Conduct Semiannual Facility Inspections due to COVID-19 Will Expire October 1, 2022

Removed 

• NOT-OD-20-088: Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19

Added to Proposal Submission & Award Management under Application Preparation

• NOT-OD-22-112: Clarification and Guidance for Applicants Preparing Applications for the Summer 2022 Due Dates During the COVID-19 Pandemic

Proposal Submission & Award Management under Post Submission Materials

• Added - NOT-OD-22-047: Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2022 Councils
• Removed previous extension notices NOT-OD-21-095 and NOT-OD-20-179 which have expired

Added to Proposal Submission & Award section under Temporary Extension of Eligibility

• NOT-OD-22-062 - Further Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic

Added to Proposal Submission & Award section under Temporary Extension of Eligibility

• NOT-DE-21-021 - Notice to Extend Eligibility for Submission of Pathway to Independence Award Applications (K99/R00) to NIDCR due to Covid-19 disruptions

Proposal Submission & Award Management under Application Preparation

• Added - NOT-OD-22-046: Clarification and Guidance for Applicants Preparing Applications for the Spring 2022 Due Dates During the COVID-19 Pandemic
• Marked NOT-OD-21-180 and  NOT-OD-21-026 "Expired"

Proposal Submission & Award Management under Post Submission Materials

• Added - NOT-OD-22-047: Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2022 Councils
• Marked NOT-OD-20-179  "Expired"

Updated Review Process during COVID-19 Pandemic graphic

• Removed May 2021 and August/October 2021 council round information
• Clarified January 2022 council round information
• Added August/October 2022 council round information

Added to Proposal Submission & Award section under Temporary Extension of Eligibility

• NOT-GM-22-020 - Notice to Extend Eligibility for Submission of "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)" Applications Due to COVID–related Disruptions

Added to Proposal Submission & Award section under Temporary Extension of Eligibility

• NOT-OD-22-007 - Flexibility Available to Lasker Clinical Research Scholars Affected by COVID-19

Added Overview of Grant Flexibilities section under Guidance and posted 

• Reminder of COVID-19-Related Flexibilities for NIH Grants: Open Mike blog

Added to Proposal Submission & Award Management section

• NOT-OD-21-180:  Clarification and Guidance for Applicants Preparing Applications for the Fall 2021 Due Dates During the COVID-19 Pandemic
• NOT-OD-21-179 Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: May 2022 Council

Removed old and rescinded information.

Added to Proposal Submission & Award Management under Temporary Extension of Eligibility

• NOT-AI-21-061 - Notice to Extend Eligibility for Submission of K99/R00 Pathway to Independence Award Applications (and Physician-Scientist K99/R00) due to COVID–related Disruptions

Added to Proposal Submission & Award Management under Temporary Extension of Eligibility

• NOT-AI-21-062 - Notice to Extend Eligibility for Submission to PAR-19-371, NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) due to COVID-related Disruptions

Added to Proposal Submission & Award Management section

• NOT-DK-21-019: NIDDK Notice of Continuation of Temporary Extension of Eligibility for the NIH Mentored Research Scientist Development Award (K01) Award During the COVID-19 Pandemic

Added to Proposal Submission & Award Management section

• NOT-DA-21-046: Notice of Information: NIDA Extensions for NRSA Fellowships and Career Development Award Recipients Whose Career Trajectories Have Been Significantly Affected by COVID-19

• Replaced rescinded notice NOT-HL-21-005 with its replacement notice NOT-HL-21-009: Updated Notice of Information: NHLBI Extensions for Career Development Award (K01, K08, K23, K25) Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19.
• The response date for RFI NOT-LM-21-005 was updated to May 28, 2021 consistent with NOT-LM-21-008.

Added to Proposal Submission & Award Management under Temporary Extension of Eligibility

• NOT-DE-21-003: Continuation of Temporary Extension of Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) During the COVID-19 Pandemic

In Proposal Submission & Award Management under Temporary Extension of Eligibility

• Added: NOT-OD-21-106: Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to
• Removed: NOT-OD-20-158: Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic

Updated Animal Welfare FAQ

• Will quorum requirements be waived in case the IACUC has to be convened to make decisions on short notice?

Added to Proposal Submission & Award Management section

• NOT-OD-21-095 Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the

Replaced NOT-OD-20-173 in Proposal Submission & Award Management with updated notice

• NOT-OD-21-080: Updated Notice of Limited Availability of Research Non-Human Primates

Removed expired Other Transaction Opportunities from Funding Opportunities section

Added to Resources section

• Infographic - 2020 NIH Extramural Surveys: The Impact of COVID-19 on the Research Communit

Added to Proposal Submission and Award Management section

• NOT-HL-21-005: Notice of Information: NHLBI Extensions for Career Development Award (K01, K08, K23, K25) Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19
• NOT-TR-21-024: Notice of Information: NCATS to Issue an Emergency Competitive Revision Sole Source Award in Support of ACTIV-6

Added FAQ to Section III: Delays in Research Progress

• 9. Can a recipient request a funded extension on a grant that is not in the final year of the project period?

Added under Funding Opportunities

• Research Opportunity Announcements for the Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Initiative administered under NIH’s Other Transaction Authority (OTA) 
  • PASC Initiative: SARS-CoV-2 Recovery Cohort Studies OTA-21-015B
  • PASC Initiative: Clinical Science Core, Data Resource Core, and PASC Biorepository Core OTA-21-015A
    
    PASC Technical Assistance Workshop
    March 1, 2021, 5 p.m. EST

Added to Funding Opportunities

• NOT-OD-21-065: Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Optional)

Removed the following outdated items:

• Overview presentation (Powerpoint)
• Overview talking points (Word)
• NOT-OD-20-122: Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic
• NOT-OD-20-123: Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic
• NOT-OD-20-172: Reminder: NIH Natural Disaster Policy – Hurricane Laura
• NOT-OD-20-161: Reminder: NIH Natural Disaster Policy – Hurricane Isaias, Derecho
• NOT-MH-20-073: Request for Information (RFI): Fostering Innovative Research to Improve Mental Health Outcomes Among Minority and Health Disparities Population

Added to Proposal Submission & Award Management section under Temporary Extension of Eligibility

• NOT-OD-21-052: Reminder – Requesting Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19

Added Request for Information

• NOT-LM-21-005: Request for Information (RFI): Use of Common Data Elements (CDEs) in NIH-funded research
  • Responses due by May 10, 2021

Added to Proposal Submission & Award Management section under Temporary Extension of Eligibility

• NOT-DK-21-054:  Temporary Extension of Eligibility for the NIDDK K01 Mentored Research Scientist Development Award During the COVID-19 Pandemic

Added to Human Subjects & Clinical Trials

• NOT-OD-21-006 - Exceptions to Use of a Single IRB During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency

Added update under Proposal Submission & Award Management

• NIH Implementation of OMB Memorandum M-20-26 "Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations"  - 6/25/2020
  • Update: Effective October 1, 2020, the flexibility for recipients to continue charging salaries and benefits to active NIH awards consistent with the recipients' policy of paying salaries (under unexpected or extraordinary circumstances), has ended. Any requests after that date will be considered by the funding IC on a case by case basis.  As a reminder, recipients must maintain appropriate records and cost documentation in order to substantiate the charging of any salaries and other project activities costs related to interruption of operations or services. 

Added update to Salary/Stipend Costs FAQs related to flexibilities for charging salaries

• Can a recipient continue to pay personnel costs under awards in the event of an emergency?
• Does the ability to charge personnel costs to NIH awards when no work is being performed also apply to summer salaries?
• If faculty at my institution are diverted from research to clinical work to care for COVID-19 patients, can the institution continue to charge their salary to an NIH grant?
• For recipients affected by COVID-19, is it appropriate to activate new awards at this time and charge salaries and benefits to them, when work cannot be performed due to COVID-19? As these are new awards, we would not be continuing to charge salaries and benefits, but to initiate these charges.

New FAQ added under Animal Welfare

• My institution received an approved waiver from OLAW to postpone conducting semiannual animal facility inspections due to COVID-19. When does this waiver expire and when must we resume conducting the inspections?

Added to Proposal Submission & Award Management

• NOT-OD-20-173: Notice of Limited Availability of Research Non-human Primates

Added to Proposal Submission & Award Management under Late Application Policy Notices

• NOT-OD-20-172: Reminder: NIH Natural Disaster Policy – Hurricane Laura
• NOT-OD-20-161: Reminder: NIH Natural Disaster Policy – Hurricane Isaias, Derecho

Added to Proposal Submission & Award Management under Temporary Extension of Eligibility

• NOT-OD-20-158: Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic

Added to Peer Review section

• Coronavirus Update: Additional Guidance for NIH Peer Reviewers (Summer 2020 Meetings/August-October 2020 Council) – June 9, 2020    

Added Request for Information section with the following RFI

• NOT-MH-20-073: Request for Information (RFI): Fostering Innovative Research to Improve Mental Health Outcomes Among Minority and Health Disparities Populations

Updated Animal Welfare FAQs

• If animals are currently in the vivarium but experiments have not started yet - can the animals be kept temporarily on a holding protocol (per diem charges still to the grant) until animals are used at the later postponed date?
• If investigators halt animal work due to the pandemic, preventing congruency with the approved protocol timeline, what is required of the investigators or the IACUC? Is it acceptable to issue a blanket statement allowing investigators to alter timelines, rather than requiring each PI to amend their study?

Updated overview presentation and overview talking points

• Overview presentation (PowerPoint)
• Overview talking points (Word)

Added to Proposal Submission & Award Management section

• Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic - NOT-OD-20-122

Removed outdated Late Application Policy Notices

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) (NOT-CA-20-082)
• Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)” ) (NOT-AI-20-058)

Revised FAQs

• All COVID-19 FAQs were reviewed and revised to align with NIH Implementation of OMB Memorandum M-20-26.  "New" and "Updated" flags added to individual FAQs as needed.

Added to Proposal Submission & Award Management under Late Application Policy Notices

• Notice to Extend Eligibility for Submission of Diversity K22 Applications due to COVID–related Disruptions - NOT-NS-20-076

New Funding Opportunities Specific to COVID-19

• Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) (PAR-20-243)
• Notice of Correction to NOT-OD-20-119, NOT-OD-20-120, NOT-OD-20-121 Eligibility Section (NOT-OD-20-138)
• Notice of Correction to NOT-OD-20-120 Eligibility Section for Budget Request Information (NOT-OD-20-141)

Added to Proposal Submission and Award Management

• NIH Implementation of OMB Memorandum M-20-26 "Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations"

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project (NOT-OD-20-129)
• Request for Proposals (RFP) Solicitation S20-119: Serological Sciences Network Capacity Building Centers (NOT-CA-20-077)

Added new chart showing the various flexibilities provided for the current and next round of peer review. 

New Information on Funding Opportunities Specific to COVID-19:

• Notice of Pre-Application Webinar for the RADx-UP Initiative (NOT-OD-20-131)
• Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) (PAR-20-237)

Added to Overview section

• Overview presentation (PowerPoint)
• Overview talking points (Word)

Revised FAQs

• Application Submission
  • Updated: Will NIH accept late applications for new awards from applicants affected by COVID-19?
  • Removed outdated late policy FAQs

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need (NOT-TR-20-029)
• NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) (PAR-20-234)
• Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-121)
• Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-120)
• Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations (NOT-OD-20-119)
• Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) (RFA-OD-20-013)

Added to Proposal Submission & Award Management section

• Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic - NOT-OD-20-123

Added to Proposal Submission & Award Management section

• Notice of NICHD Participation in NOT-EB-20-012 "Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)" - NOT-HD-20-017

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (NOT-MH-20-053)
• Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations (NOT-MD-20-022)
• Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) (RFA-CA-20-039)
• Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) (RFA-CA-20-038)
• Update to NOT-OD-20-107 - Notice of Change in Application Due Date for NOT-OD-20-107 "Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for COVID-19 – related Research" (NOT-OD-20-117)

Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency caused by Coronavirus Disease 2019 (COVID-19) (NOT-MH-20-061)

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders (NOT-DC-20-008)
• Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional) (NOT-MH-20-058)
   

New Funding Opportunities Specific to COVID-19

• Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) (NOT-MD-20-023)

Replaced NHGRI Late Application Policy Notice NOT-HG-20-041 with  Rescinding NOT-HG-20-041 “NHGRI Late Application Policy for NHGRI-Specific FOAs with Application Due Dates in May, June, and July” and Clarifying the Late Application Receipt Dates of NHGRI-Specific FOAs - NOT-HG-20-042

New Funding Opportunities Specific to COVID-19

• Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives (NOT-OD-20-112)

Updated document Considerations for New and Ongoing Human Subjects Research During the COVID-19 Public Health Emergency

• Added link to website for FDA application that allows investigators to obtain electronic informed consent

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) – related Research (NOT-OD-20-107)
• Update to NOT-NS-20-051: Notice of Change to Eligible Activity Codes for NOT-NS-20-051 "Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System" (NOT-NS-20-074)

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) (NOT-AT-20-012)

Added to Proposal Submission & Award Management section

• Notice of Change: Late Application Policy for June 17, 2020, Application Due Date of PAR-19-242, Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Due to Public Health Emergency for US Coronavirus Disease 2019 - NOT-CA-20-069
• Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19) - NOT-EB-20-012
• NHGRI Late Application Policy for NHGRI-Specific FOAs with Application Due Dates in May, June, and July - NOT-HG-20-041

New Funding Opportunities Specific to COVID-19

• NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional) (RFA-RM-20-021)
• NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional) (RFA-RM-20-020)

Added updated files for:

• Overview presentation (Powerpoint)
• Overview talking points (Word)

New/revised FAQs

• Financial and Performance Reporting (RPPR)
  • How should recipients submit details on how COVID-19 has delayed or affected the progress of research activities on NIH-funded grant projects?
• Foreign Components
  • If a post-doc on an active NIH grant must return home, to a foreign country, and work remotely due to COVID-19, must this be reported to NIH as a foreign component?
• Costs - Salary/Stipend Costs
  • For recipients affected by COVID-19, is it appropriate to activate new awards at this time and charge salaries and benefits to them, when work cannot be performed due to COVID-19? As these are new awards, we would not be continuing to charge salaries and benefits, but to initiate these charges.
  • If institutional funds are not available, can recipients affected by COVID-19 supplement NRSA stipends with funds from other federal awards?
• Training, Fellowship and Career Development
  • Can an international student who is unable to physically arrive in the U.S. to start their program this fall because of COVID-related travel restrictions, but who is participating in on-line distance education, be supported from federal grants? Can tuition be charged to the grant on which the faculty member intends for them to work when they arrive in the U.S.?
  • Can international students and post-docs continue to be supported on NIH grant projects if they are not able to return to the U.S. because of COVID-19 related travel restrictions?
  • Is NIH providing any COVID-19 related flexibilities to post-doctorates who’ve received Kirschstein-NRSA support and have payback obligations?

Added to Proposal Submission & Award Management section

• NICHD Late Application Policy for Institutional Training Grants to RFA-HD-21-014 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19) NOT-HD-20-016
• NIGMS Late Application Policy for NIGMS-Specific FOAs with Application Due Dates in May 2020 - NOT-GM-20-029
• UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) - NOT-OD-20-091

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-AI-20-051)
• Update to NOT-AI-20-031: Notice of Early Expiration of “Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)"

Added to Proposal Submission & Award Management section

• Late Application Policy for May 25, 2020, Application Due Date of NCI's Cancer Research Education Grants Program (R25) Funding Opportunity Announcements PAR-18-476, PAR-18-477, and PAR-18-478 Due to Public Health Emergency for US Coronavirus Disease 2019 - NOT-CA-20-068 under Proposal Submission & Award Management 

New Funding Opportunities Specific to COVID-19

• Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence (NOT-CA-20-066)

Added to Proposal Submission & Award Management section

• NIH Late Application Policy for Institutional Training Grants to PA-20-142 and PA-20-162 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19) - NOT-OD-20-105
  • T32 and T35 training grant applications submitted to the parent funding opportunity announcements PA-20-142 and PA-20-162 with a due date of May 25 will be accepted through June 30, 2020.

New Funding Opportunities Specific to COVID-19 

• Notice of Additional Due Date and Additional “Areas of Focus Especially of Interest” of PAR-19-373 and PAR-19-384, "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)" (NOT-OD-20-103)

New Funding Opportunities Specific to COVID-19 

• Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network (NOT-DE-20-023)
• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR (NOT-DE-20-022)

New Funding Opportunities Specific to COVID-19 

• NIH Rapid Acceleration of Diagnostics (RADx) Initiative for COVID-19 (released 4/29/2020)

New/revised FAQs

• General
  • Is NIH providing flexibility on the requirements related to the use of Human Fetal Tissue (HFT) in NIH-funded research, in response to the public health emergency?
  • Where can I find information on NIH-funded trials and studies involving COVID-19?
  • What controls, if any, has NIH established for managing funding and activities related to the COVID-19 response? How will NIH management balance the need to implement the program quickly and maintain strong internal controls and manage the associated risks?
• Application Submission
  • What guidance are reviewers being given as they consider applications during the COVID-19 pandemic?
  • What should I do if I don’t have enough preliminary data for my application?
  • Do applicants have to apply for supplemental funds from the same IC that funded the parent grant?
  • What happens if an institution has already submitted an application, and due to effects of COVID-19, some of the information needs to be revised?
• Financial and Performance Reporting
  • Is NIH providing flexibility to S10 recipients, who may be unable to submit on-time Annual Usage Reports, or unable to fulfill institutional usage commitments?
• Costs - Salary/Stipend Costs
  • Can a recipient continue to pay personnel costs under awards in the event of an emergency?
  • Does the ability to charge personnel costs to NIH awards when no work is being performed also apply to summer salaries?
  • For recipients affected by COVID-19, is it appropriate to activate new awards at this time and charge salaries and benefits to them, when work cannot be performed due to COVID-19? As these are new awards, we would not be continuing to charge salaries and benefits, but to initiate these charges.
• Costs - Prior Approvals
  • Can recipients donate Personal Protective Equipment (PPE) and supplies acquired with NIH grant funds to local hospitals and health care facilities in support of COVID-19 efforts?
• Human Subjects
  • Is NIH providing flexibility to recipients for late results reporting in ClinicalTrails.gov due to COVID-19?
• Training, Fellowship and Career Development
  • Given the current COVID-19 situation resulting in office closures, are fellows still required to mail Individual Fellowship Activation Notice forms containing original signatures or are emailed forms with electronic or typed signatures adequate?
  • For phased awards such as the K22 and K99/R00, where recipients are not able to transition due to COVID-19, will NIH consider extensions for obtaining faculty positions?
  • Are childcare costs allowable charges to grants? Can they be charged for both PIs and for trainees for childcare costs need? Is this a usual allowable cost or a flexibility during the COVID pandemics?

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System (NOT-NS-20-051)
• Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) (PAR-20-177)
• Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) (PAR-20-178)
• Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis (NOT-CA-20-054)

Added link to Considerations for New and Ongoing Human Subjects Research During the COVID-19 Public Health Emergency under Human Subjects

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs (NOT-TR-20-028)

Added updated files for:

• Overview presentation (Powerpoint)
• Overview talking points (Word) 

Added updates to previously posted Funding Opportunities Specific to COVID-19

• NOT-AG-20-022
  • April 21, 2020 Update (NOT-AG-20-031): Frequently Asked Questions for NOT-AG-20-022 Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
• NOT-DC-20-004
  • April 20, 2020 Update (NOT-DC-20-006): Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19

Added links under Human Subjects

• OHRP COVID-19 Resources
• Live Videocast on Tuesday, April 28 from 1-2pm ET

Added link to Coronavirus Update: Guidance for Peer Reviewers

New FAQs

• Animal Welfare
  • How may the IACUC extend a protocol that is due to expire and still meet the PHS Policy requirements?

New FAQs

• Application Submission
•  Is NIH providing flexibility for the required registrations for organizations to submit an application to NIH?
• Human Subjects
• My study was delayed during the COVID-19 public health emergency and I will not finish my project by the CoC expiration date. Can I get an extension on my CoC?
• ​​​Training, Fellowship, and Career Development Awards
• For non-phased K awards (K01, K08, K23, K25) will NIH permit requests for continued support or extensions due to COVID-19?
• If a T35 program is shortened, will the trainees’ stipend be decreased?
• Are institutions obligated to pay students if they have recruited them to a short-term T35 training program, but the training program was cancelled before it started?
• Can recipients change the originally proposed format of a T35 program by devising an electronic curriculum rather than in-person experiences?
• Can recipients shorten a T35 program, from 3 months to shorter periods (e.g. July and August)?
• Can recipients cancel the T35 program for this summer due to COVID issues?
• If a T35 program is shortened or cancelled can the unused funds carryover to the following year?
• What should K awardees do if they need to stop all research activities in order to provide clinical care (to COVID19 patients)?
• How will carryover for institutional training grants (e.g. T35, T32, K12) be handled?

• New NIH Resource to Analyze COVID-19 Literature: The COVID-19 Portfolio Tool

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest:  Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA (NOT-AA-20-011)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) (NOT-LM-20-010)

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2 (NOT-NS-20-046)

Updates to Resource section

• Supporting Yourself and Your Trainees During the Coronavirus Pandemic Online Workshops
• NIH Office of Intramural Training & Education: Virtual NIH Activities for Trainees Outside the NIH

Updates to Animal Welfare section

• Removed OLAW webinar link

Added link to OHRP Guidance on COVID-19 under Human Subjects and Clinical Trials

Added link to COVID-19 Funding and Funding Opportunities – Open Mike Blog under Funding

Added link to Virtual NIH Activities for Trainees Outside the NIH under Resources

New/revised FAQs

• General
  • Do the flexibilities outlined in the recent guide notices and these FAQs apply to contracts, in addition to grants and cooperative agreements?
• Application Submission
  • What happens if an institution has already submitted an application, and due to effects of COVID-19, some of the information needs to be revised?
  • Does the late application policy outlined in NOT-OD-20-091 apply to continuous submission deadlines?
  • Will NIH accept late submissions of reference letters?
  • NIH has stated that it will accept late applications for due dates from March 9, 2020 through May 1, 2020. If my institution has already submitted an application, can it be withdrawn? Can it be resubmitted during this period of flexibility?
• Financial and Performance Reporting
  • How should recipients notify NIH that closeout reports will be late?
• Foreign Components (new category)
  • If a post-doc on an active NIH grant must return home to a foreign country and work remotely due to COVID-19, must this be reported to NIH as a foreign component?
• Costs - Salary/Stipend Costs
  • Can a recipient continue to pay personnel costs under awards in the event of an emergency?
  • If faculty at my institution are diverted from research to clinical work to care for COVID-19 patients, can the institution continue to charge their salary to an NIH grant?
• Costs - Prior Approvals
  • Can recipients donate Personal Protective Equipment (PPE) and supplies acquired with NIH grant funds to local hospitals and health care facilities in support of COVID-19 efforts?
  • Our institution has closed the lab for all but maintenance activities at this time. While we understand that charges for salaries, animal care, and other expenses may be allowable during this closure, will additional funds (e.g. from administrative supplements) be made available to support the lost time?
  • Is prior approval required if my institution plans to divert staff from research to clinical work to care for COVID-19 patients or to work on COVID-19 research activities?
• Costs - Other Costs (new sub-category)
  • Since most investigators are teleworking, can institutions now purchase laptops, desktops and other equipment using grant funds, to aid in telework?
• Human Subjects
  • Is NIH offering COVID-19-related flexibilities for updating and correcting study information in ClinicalTrials.gov?
• Training, Fellowship and Career Development
  • For phased awards (e.g. K22, K99, etc.) or other training, fellowship and career development awards where extensions are typically limited, will NIH consider extensions due to COVID-19?
  • For phased awards such as the K22 and K99/R00, where recipients are not able to transition due to COVID-19, will NIH consider extensions for obtaining faculty positions?
  • Can I request an extension for a Ruth L. Kirschstein National Research Service Award (NRSA) and/or fellowship award?
  • Will there be a single NIH-wide policy to cancel, shorten the duration, or create alternate (e.g., remote) training opportunities for summer T35 programs?
  • If a T32/T35 is cancelled or shortened, or is unable to fill all slots because of COVID-19, what will happen to the unused funds?

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (NOT-OD-20-097)

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (NOT-ES-20-020)
• Notice of Early Expiration of NOT-ES-20-015, "Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (NOT-ES-20-019)
• Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)" (NOT-ES-20-016)
• Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NOT-EB-20-008)
• Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NOT-EB-20-007)
• Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NOT-EB-20-006)
• Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 (NOT-GM-20-027)
• Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) (NOT-AT-20-011)
• Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) (CA-20-042)

New notice on Guidance for Cost-Related Flexibilities Available to Support of Competitive Research (SCORE) Award Recipients Affected by COVID-19

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission (NOT-DK-20-020)
• Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities (NOT-MD-20-019)
• Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus (NOT-TR-20-017)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus (NOT-MH-20-047)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus (NOT-TR-20-016)
• Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-CA-20-043)
• Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (NOT-ES-20-015)
• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK (NOT-DK-20-018)
• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) (NOT-DC-20-004)
• NHLBI Announces Availability of Frequently Asked Questions (FAQs) for NOT-HL-20-757, Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-HL-20-759)

Added Overview section with the following items:

• Overview presentation (Powerpoint) - updated on April 21, 2020 
• Overview talking points (Word) - updated on April 21,  2020

Updated Guidance: Animal Welfare

• Added link to COVID-19 Pandemic Contingency Planning for Animal Care and Use Programs page
  • Page no longer active - see COVID-19 Pandemic Contingency Planning for Animal Care and Use Programs page 5/16/2023 archive

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

Updated Guidance: Proposal Submission & Award Management

• Contracts must be handled on a case by case basis. Details regarding any contract must be directed to the cognizant Contracting Officer. Salary changes must be handled by the contracting officer.

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-HG-20-030)

New/Revised FAQs

• Substantial additions to Animal Welfare FAQs
• Prior Approval
  • Can recipients that are not covered under Streamlined Non-competing Application Process (SNAP) carry forward unobligated balances on their active awards that are affected by COVID-19?
  • Can recipients donate Personal Protective Equipment (PPE) and supplies acquired with NIH grant funds to local hospitals and health care facilities in support of COVID-19 efforts?
• Training, Fellowship and Career Development Awards
  • Can a K99 applicant apply for an extension of the 4-year eligibility window (for initial applications or resubmissions) due to COVID-19? 

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) (NOT-AI-20-030)
• Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) (NOT-ES-20-014)
• Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)  ​(NOT-TR-20-012)

Updated Guidance: Proposal Submission & Award Management

• UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) - NOT-OD-20-091 

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-20-025)
• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047)
• Notice of Special Interest (NOSI) Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need (NOT-R-20-111)
• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-20-025)

FAQs

• Substantial updates to FAQs including new section on Training, Fellowship and Career Development Awards

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI) Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need (NOT-TR-20-011)

Webinar: Animal Welfare

• OLAW Webinar: Pandemic Contingency Planning and Its Impact on Animal Care

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047)

Updated Guidance: Animal Welfare

• Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19 - NOT-OD-20-088
   

New Funding Opportunities Specific to COVID-19

• Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NOT-HL-20-757)

Updated Guidance: Human Subjects & Clinical Trials

• Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 - NOT-OD-20-087

Updated Guidance: Proposal Submission & Award Management

• Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 - NOT-OD-20-086

Updated Guidance: Proposal Submission & Award Management

• NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) - NOT-OD-20-082 (Updated March 26 - NOT-OD-20-091)